Open AccessP1532: SUTIMLIMAB AFTER PRIOR RITUXIMAB USE IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): POOLED POST‐HOC ANALYSES FROM THE CARDINAL AND CADENZA TRIALS
Author(s) -
Röth A.,
Karaouni A.,
Msihid J.,
Hemim I.,
Joly F.,
Shafer F.,
Sourdille T.,
Hill Q.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000848984.06528.b5
Subject(s) - medicine , rituximab , post hoc analysis , cold agglutinin disease , clinical endpoint , placebo , post hoc , anemia , gastroenterology , surgery , clinical trial , autoimmune hemolytic anemia , pathology , lymphoma , alternative medicine